They stratified patients by both ejection fraction (reduced, preserved, and not classifiable) and heart failure severity. ... Of these, 5,839 were hospitalized at the health system for heart failure during the study period.
How does that cohort generalize to the millions of elderly, female, and nonwhite [heart failure] patients with comorbid diseases?” Dr. ... In April, the FDA approved another novel drug, ivabradine (Corlanor), to reduce hospitalizations from worsening
While increasing heart failure treatment intensity reduced risk of death and rehospitalization among hospitalized patients, the use of guideline-recommended dual and triple therapies was low, a study found. ... Almost half (46%) of patients who received
Heart failure results from functional or structural abnormalities that impair diastolic filling or systolic ejection of blood. ... Echocardiogram is the usual method for identifying systolic and diastolic heart failure based on ejection fraction.
The industry-funded trial found similar rates of renal failure, hyperkalemia, symptomatic hypotension, and angioedema whether patients started sacubitril-valsartan or enalapril during their heart failure hospitalization. ... lower rate of readmission for
The most common diagnosis at admission was heart failure with reduced ejection fraction of 45% or lower, which was present in 37.2% of patients. ... Results of the study were published by JACC: Heart Failure on June 10 and appeared in the July 1 issue.
Thirty-day mortality rates may be an effective measure of hospitals' quality of care for heart failure (HF) patients, according to a new study.
who represent about half of all heart failure patients, according to current guidelines. ... Clinical inertia is a major driver of the gap between heart failure evidence and practice, said Dr.
therapy to reduce morbidity and mortality in patients with chronic symptomatic heart failure with reduced ejection fraction. ... Head-to-head comparisons of an ARB versus ARNI for heart failure do not exist.
A 57-year-old woman is evaluated in the hospital for chronic systolic heart failure. ... The routine treatment of patients with heart failure with warfarin is not indicated.